Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women

@article{Provinciali2016RaloxifeneHF,
  title={Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women},
  author={N. Provinciali and C. Suen and B. Dunn and A. Decensi},
  journal={Expert Review of Clinical Pharmacology},
  year={2016},
  volume={9},
  pages={1263 - 1272}
}
ABSTRACT Introduction: Raloxifene is an estrogen receptor modulator which competes with estrogens for binding to the estrogen receptor. Based on the results of the STAR (Study of Tamoxifen And Raloxifene) trial, raloxifene has been approved by the U.S. Food and Drug Administration for the reduction of breast cancer (BC) risk in postmenopausal women at increased risk. Areas covered: This analysis reviews the activity of raloxifene and the clinical trials for non-BC indications which led to… Expand
12 Citations
Combined Raloxifene and Letrozole for Breast Cancer Patients.
  • 4
Pharmacotherapy for schizophrenia in postmenopausal women
  • 12
Drug repurposing for breast cancer therapy: Old weapon for new battle
  • 15
Transcription Factors in Cancer Development and Therapy
  • 3
  • PDF
...
1
2
...

References

SHOWING 1-10 OF 94 REFERENCES
Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action.
  • 40
Review on raloxifene: profile of a selective estrogen receptor modulator.
  • M. Heringa
  • Medicine
  • International journal of clinical pharmacology and therapeutics
  • 2003
  • 70
Raloxifene: a selective estrogen receptor modulator.
  • 41
Clinical effects of raloxifene hydrochloride in women.
  • 43
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
  • 690
  • PDF
Pharmacokinetics of raloxifene and its clinical application.
  • D. Hochner-Celnikier
  • Medicine
  • European journal of obstetrics, gynecology, and reproductive biology
  • 1999
  • 124
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
  • E. Lewiecki
  • Medicine
  • Therapeutics and clinical risk management
  • 2009
  • 11
  • PDF
Use of SERMs for treatment in postmenopausal women
  • 100
Raloxifene use in clinical practice: efficacy and safety
  • 30
...
1
2
3
4
5
...